European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
23 sept. 2024 08h00 HE
|
European Microbiome Innovation for Health
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement Paris, France, September 23, 2024, 2:00 pm CET - The European Microbiome...
Floré Unveils World’s First Line of Probiotics for Neurodiversity
19 sept. 2024 09h00 HE
|
Flore
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Floré, a leader in gut health testing and customized probiotics, has launched its new line of probiotics specifically designed for neurodiversity. The...
Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies
27 août 2024 04h00 HE
|
Microbiotica
CAMBRIDGE, United Kingdom, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Microbiotica, a biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products...
2024 Microbiome Market Trends Report: Competitive Environment Analysis, Digital Platform and Marketing Strategies, and AI Adoption in the Industry
22 août 2024 10h56 HE
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "2024 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. In the microbiome therapeutics market, some microbiome...
Human Microbiome Market Projected to Surpass to $3 Billion by 2032 with DuPont, Evelo Bio, Finch Therapeutics, Ginkgo Bioworks, Seres Therapeutics, AOBiome, Astarte Medical, Axial Biotherapeutics
14 août 2024 09h02 HE
|
Research and Markets
Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market Report by Application Disease Product, Countries and Company Analysis, 2024-2032" report has been added to ...
Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity
13 août 2024 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy aging, is excited to...
Canada's First Precision Health and Longevity Summit Aims to Advance Global Healthspan Research
08 août 2024 09h47 HE
|
BioAro
Join Canada’s first Precision Health & Longevity Summit on Nov 16, 2024, at The Westin Calgary. Explore innovations in precision medicine & healthspan.
Microbiotica to Present Positive Update on Manufacturing Progress of its Live Biotherapeutic Products for Forthcoming Melanoma and Ulcerative Colitis Clinical Studies
09 juil. 2024 04h00 HE
|
Microbiotica
Presentation in Boston at 9th Microbiome Movement Drug Development Summit, 10-12 July 2024 CAMBRIDGE, UK , July 09, 2024 (GLOBE NEWSWIRE) -- Microbiotica, a biopharma company developing a pipeline...
Global Microbiome Diagnostics Research Report 2024: 16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics Forecast to 2028
01 juil. 2024 10h29 HE
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Global Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics,...
Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market
27 juin 2024 11h11 HE
|
The Akkermansia Company
The Akkermansia Company, founded by the first scientists to discover and decode Akkermansia muciniphila, announces its launch into the U.S. consumer market